Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor
- PMID: 8589719
- DOI: 10.1038/ng0396-280
Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor
Erratum in
- Nat Genet 1996 May;13(1):129
Abstract
Mice that have been made deficient for the cystic fibrosis transmembrane conductance regulator (Cftr) usually die of intestinal obstruction. We have created Cftr-deficient mice and demonstrate prolonged survival among backcross and intercross progeny with different inbred strains, suggesting that modulation of disease severity is genetically determined. A genome scan showed that the major modifier locus maps near the centromere of mouse chromosome 7. Electrophysiological studies on mice with prolonged survival show that the partial rectification of Cl- and Na+ ion transport abnormalities can be explained in part by up-regulation of a calcium-activated Cl- conductance. Identification of modifier genes in our Cftr(m1HSC)/Cftr(m1HSC) mice should provide important insight into the heterogeneous disease presentation observed among CF patients.
Similar articles
-
In vivo measurements of ion transport in long-living CF mice.Biochem Biophys Res Commun. 1996 Feb 27;219(3):753-9. doi: 10.1006/bbrc.1996.0306. Biochem Biophys Res Commun. 1996. PMID: 8645253
-
Cystic fibrosis in the mouse by targeted insertional mutagenesis.Nature. 1992 Sep 17;359(6392):211-5. doi: 10.1038/359211a0. Nature. 1992. PMID: 1382232
-
Toll-like receptor-4 genotype influences the survival of cystic fibrosis mice.Am J Physiol Gastrointest Liver Physiol. 2010 Aug;299(2):G381-90. doi: 10.1152/ajpgi.00003.2010. Epub 2010 Jun 3. Am J Physiol Gastrointest Liver Physiol. 2010. PMID: 20522639
-
Selective activation of cystic fibrosis transmembrane conductance regulator Cl- and HCO3- conductances.JOP. 2001 Jul;2(4 Suppl):212-8. JOP. 2001. PMID: 11875262 Review.
-
Cystic fibrosis transmembrane conductance regulator (CFTR) and renal function.Wien Klin Wochenschr. 1997 Jun 27;109(12-13):457-64. Wien Klin Wochenschr. 1997. PMID: 9261986 Review.
Cited by
-
Latent TGF-beta-binding protein 4 modifies muscular dystrophy in mice.J Clin Invest. 2009 Dec;119(12):3703-12. doi: 10.1172/JCI39845. Epub 2009 Nov 2. J Clin Invest. 2009. PMID: 19884661 Free PMC article.
-
Chloride channel diseases resulting from impaired transepithelial transport or vesicular function.J Clin Invest. 2005 Aug;115(8):2039-46. doi: 10.1172/JCI25470. J Clin Invest. 2005. PMID: 16075045 Free PMC article. Review.
-
Mouse genomic variation and its effect on phenotypes and gene regulation.Nature. 2011 Sep 14;477(7364):289-94. doi: 10.1038/nature10413. Nature. 2011. PMID: 21921910 Free PMC article.
-
Genetic background influences tumour development in heterozygous Men1 knockout mice.Endocr Connect. 2020 May;9(5):426-437. doi: 10.1530/EC-20-0103. Endocr Connect. 2020. PMID: 32348957 Free PMC article.
-
Effect of genistein on basal jejunal chloride secretion in R117H CF mice is sex and route specific.Clin Exp Gastroenterol. 2015 Jan 30;8:77-87. doi: 10.2147/CEG.S72111. eCollection 2015. Clin Exp Gastroenterol. 2015. PMID: 25674010 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases